Mild Pd-catalyzed N -arylation of methanesulfonamide and related nucleophiles: Avoiding potentially genotoxic reagents and byproducts

Organic Letters

Volumn 13, Issue 10, 2011, Pages 2564-2567

  Rosen, Brandon R ^a   Ruble, J Craig ^a   Beauchamp, Thomas J ^a   Navarro, Antonio ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMINATED HYDROCARBON; CHLORINATED HYDROCARBON; DOFETILIDE; METHANESULFONAMIDE; PALLADIUM; PHENETHYLAMINE DERIVATIVE; SULFONAMIDE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; SYNTHESIS;

CATALYSIS; COMBINATORIAL CHEMISTRY TECHNIQUES; HYDROCARBONS, BROMINATED; HYDROCARBONS, CHLORINATED; MOLECULAR STRUCTURE; PALLADIUM; PHENETHYLAMINES; SULFONAMIDES;

EID: 79956125322     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol200660s     Document Type: Article

References (46)

1. For a list of marketed drugs containing a sulfonamide, see: Smith, D. A.; Jones, R. M. Curr. Opin. Drug Discovery Dev. 2008, 11, 72-79
2. Snodin, D. J. Org. Process Res. Dev. 2010, 14, 960-976
3. Pierson, D. A.; Olsen, B. A.; Robbins, D. K.; DeVries, K. M.; Varie, D. L. Org. Process Res. Dev. 2009, 13, 285-291
4. Teasdale, A.; Delaney, E. J.; Eyley, S. C.; Jacq, K.; Taylor-Worth, K.; Lipczynski, A.; Hoffmann, W.; Reif, V.; Elder, D. P.; Facchine, K. L.; Golec, S.; Oestrich, R. S.; Sandra, P.; David, F. Org. Process Res. Dev. 2010, 14, 999-1007
5. Ullmann, F.; Junghans, W. Annalen 1913, 399, 330-345
6. For a review, see: Lindley, J. Tetrahedron 1984, 40, 1433-1456
7. Wolfe, J. P.; Rennels, R. A.; Buchwald, S. L. Tetrahedron 1996, 52, 7525-7546
8. 3 where possible due, in part, to its high molar cost when compared to several other common bases.
9. For examples employing Cu catalysis, see: He, H.; Wu, Y.-J. Tetrahedron Lett. 2003, 44, 3385-3386
10. Steinhuebel, D.; Palucki, M.; Askin, D.; Drolling, U. Tetrahedron Lett. 2004, 45, 3305-3307
11. Baffoe, J.; Hoe, M. Y.; Touré, B. B. Org. Lett. 2010, 12, 1532-1535
12. Han, X. Tetrahedron Lett. 2010, 51, 360-362
13. For examples employing Pd catalysis, see: Yin, J.; Buchwald, S. L. Org. Lett. 2000, 2, 1101-1104
14. Burton, G.; Cao, P.; Li, G.; Rivero, R. Org. Lett. 2003, 5, 4373-7376
15. Steinhuebel, D.; Palucki, M.; Askin, D.; Drolling, U. Tetrahedron Lett. 2004, 45, 3305-3307
16. Ikawa, T.; Barder, T. E.; Biscoe, M. R.; Buchwald, S. L. J. Am. Chem. Soc. 2007, 129, 13001-13009
17. Anjanappa, P.; Mullick, D.; Selvakumar, K.; Sivakumar, M. Tetrahedron Lett. 2008, 49, 4585-4587
18. Hicks, J. D.; Hyde, A. M.; Cuezva, A. M.; Buchwald, S. L. J. Am. Chem. Soc. 2009, 131, 16720-16734
19. For Cu-catalyzed arylation of sulfonamides with boronic acids, see: Lam, P. Y. S.; Vincent, G.; Clark, C. G.; Deudon, S.; Jadhav, P. K. Tetrahedron Lett. 2001, 42, 3415-3418
20. Pan, C.; Cheng, J.; Wu, H.; Ding, J.; Liu, M. Synth. Commun. 2009, 39, 2082-2092
21. For arylation of sulfonamides via reaction with benzynes, see: Liu, Z.; Larock, R. C. Org. Lett. 2003, 5, 4673-4675
22. We have verified that methanesulfonamide provides a negative result in a mini-Ames test.
23. For representative examples, see: Deng, W.; Liu, L.; Zhang, C.; Liu, M.; Guo, Q.-X. Tetrahedron Lett. 2005, 46, 7295-7298
24. Dragovich, P. S. Bioorg. Med. Chem. Lett. 2008, 18, 5635-5639
25. Reference 8a.
26. Reference 8c.
27. Reference 8d.
28. Briggs, J. R.; Klosin, J.; Whiteker, G. T. Org. Lett. 2005, 7, 4795-4798
29. Dinsmore, C. J.; Ortega, A. E. G.; Guerin, D. J.; Jewell, J. P.; Katz, J. D.; Lim, J.; Machacek, M. R.; Otte, R. D.; Young, J. R. U.S. Patent Application 2006/0293358 A1, 2006.
30. Blake, J. F.; Fell, J. B.; Fischer, J. P.; Hendricks, R. T.; Spencer, S. R.; Strengel, P. J. International Patent Application WO2006117306 A1, 2006.
31. Kelly, M.; Lee, Y.; Liu, B.; Fujimoto, T.; Freundlich, J.; Dorsey, B. D.; Flynn, G. A.; Husain, A.; Moore, W. R., Jr. U.S. Patent Application 2008/0280891 A1, 2008.
32. Surry, D. S.; Buchwald, S. L. Angew. Chem., Int. Ed. 2008, 47, 6338-6361
33. Bünger, J.; Stork, J.; Stalder, K. Int. Arch. Occup. Environ. Health 1996, 69, 33-38
34. Garrett, C. E.; Prasad, K. Adv. Synth. Catal. 2004, 346, 889-900
35. Conditions very similar to these were employed in ref 9f for the coupling of larger sulfonamides with aryl sulfonates.
36. 2; see: Klingensmith, L. M.; Strieter, E. R.; Barder, T. E.; Buchwald, S. L. Organometallics 2006, 25, 82-91
37. In the case of the IPr ligand, 5 mol % of the preformed (IPr)Pd(allyl)Cl complex was used without an additional ligand; see: Viciu, M. S.; Navarro, O.; Germaneau, R. F.; Kelly, R. A., III; Sommer, W.; Marion, N.; Stevens, E. D.; Cavallo, L.; Nolan, S. P. Organometallics 2004, 23, 1629-1635
38. Although Bippyphos did not result in the fastest reactions, the lack of IP surrounding this ligand could make it an attractive alternative for some applications; see: Singer, R. A.; Doré, M.; Sieser, J. E.; Berliner, M. A. Tetrahedron Lett. 2006, 47, 3727-3731
39. A palladium loading of 2 mol % was used with 3 mol % of ligand.
40. Biscoe, M. R.; Fors, B. P.; Buchwald, S. L. J. Am. Chem. Soc. 2008, 130, 6686-6687
41. Fors, B. P.; Krattiger, P.; Strieter, E.; Buchwald, S. L. Org. Lett. 2008, 10, 3505-3508
42. We have confirmed that the use of freshly prepared catkit provides results equivalent to those obtained when each component is added separately; however, this particular mix does turn gray over days to weeks and should no longer be used once that is observed.
43. No evidence of N -(4-bromophenyl)methanesulfonamide was observed in the crude GCMS of the reaction.
44. See Supporting Information for list of failed haloheterocycles.
45. Shagufta; Guo, D.; Klaasse, E.; de Vries, H.; Brussee, J.; Nalos, L.; Rook, M. B.; Vos, M. A.; van der Heyden, M. A. G.; IJzerman, A. P. ChemMedChem 2009, 4, 1722-1732
46. The Pd level in our isolated dofetilide was 535 ppm.